Integra Lifesciences Holdings Stock Price History
| IART Stock | USD 12.21 0.34 2.86% |
Below is the normalized historical share price chart for Integra LifeSciences Holdings extending back to August 16, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Integra LifeSciences stands at 12.21, as last reported on the 27th of June, with the highest price reaching 12.22 and the lowest price hitting 11.65 during the day.
If you're considering investing in Integra Stock, it is important to understand the factors that can impact its price. Integra LifeSciences holds Efficiency (Sharpe) Ratio of -0.19, which attests that the entity had a -0.19 % return per unit of risk over the last 3 months. Integra LifeSciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Integra LifeSciences' Standard Deviation of 4.41, market risk adjusted performance of (0.60), and Risk Adjusted Performance of (0.32) to validate the risk estimate we provide. At this time, Integra LifeSciences' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 4.2 B in 2025, whereas Common Stock Total Equity is likely to drop slightly above 528.7 K in 2025. . At this time, Integra LifeSciences' Price Earnings To Growth Ratio is comparatively stable compared to the past year. Price To Free Cash Flows Ratio is likely to gain to 73.46 in 2025, whereas Price To Sales Ratio is likely to drop 1.03 in 2025. Integra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of August 1995 | 200 Day MA 19.8539 | 50 Day MA 13.7852 | Beta 1.171 |
Sharpe Ratio = -0.1853
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IART |
Estimated Market Risk
| 4.59 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.85 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Integra LifeSciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integra LifeSciences by adding Integra LifeSciences to a well-diversified portfolio.
Price Book 0.6052 | Enterprise Value Ebitda 14.7985 | Price Sales 0.5679 | Shares Float 61.8 M | Wall Street Target Price 16.125 |
Integra LifeSciences Stock Price History Chart
There are several ways to analyze Integra Stock price data. The simplest method is using a basic Integra candlestick price chart, which shows Integra LifeSciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 31, 2025 | 21.99 |
| Lowest Price | June 20, 2025 | 11.6 |
Integra LifeSciences June 27, 2025 Stock Price Synopsis
Various analyses of Integra LifeSciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Integra Stock. It can be used to describe the percentage change in the price of Integra LifeSciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Integra Stock.| Integra LifeSciences Accumulation Distribution | 64,545 | |
| Integra LifeSciences Price Rate Of Daily Change | 1.03 | |
| Integra LifeSciences Price Action Indicator | 0.45 | |
| Integra LifeSciences Price Daily Balance Of Power | 0.60 |
Integra LifeSciences June 27, 2025 Stock Price Analysis
Integra Stock Price History Data
The price series of Integra LifeSciences for the period between Sat, Mar 29, 2025 and Fri, Jun 27, 2025 has a statistical range of 11.04 with a coefficient of variation of 22.1. Under current investment horizon, the daily prices are spread out with arithmetic mean of 15.43. The median price for the last 90 days is 13.67. The company completed 2:1 stock split on 4th of January 2017.| Open | High | Low | Close | Volume | ||
06/26/2025 | 11.87 | 12.22 | 11.65 | 12.21 | 1,383,753 | |
| 06/25/2025 | 11.88 | 12.01 | 11.62 | 11.87 | 1,415,912 | |
06/24/2025 | 11.81 | 12.07 | 11.65 | 11.87 | 1,546,543 | |
06/23/2025 | 11.50 | 11.66 | 11.06 | 11.62 | 1,658,267 | |
06/20/2025 | 12.10 | 12.14 | 11.59 | 11.60 | 2,360,283 | |
| 06/18/2025 | 12.16 | 12.40 | 11.88 | 11.91 | 1,270,524 | |
06/17/2025 | 12.15 | 12.59 | 12.01 | 12.15 | 1,345,560 | |
06/16/2025 | 12.41 | 12.47 | 11.99 | 12.39 | 1,524,331 | |
06/13/2025 | 12.40 | 12.67 | 12.12 | 12.16 | 954,244 | |
06/12/2025 | 12.72 | 13.09 | 12.53 | 12.69 | 1,696,766 | |
| 06/11/2025 | 13.99 | 14.11 | 12.64 | 12.83 | 2,164,359 | |
| 06/10/2025 | 14.06 | 14.41 | 13.79 | 13.98 | 2,464,710 | |
| 06/09/2025 | 13.53 | 14.28 | 13.53 | 13.88 | 1,179,849 | |
| 06/06/2025 | 13.56 | 13.94 | 13.49 | 13.56 | 1,149,348 | |
06/05/2025 | 13.10 | 13.61 | 12.93 | 13.29 | 901,577 | |
06/04/2025 | 13.07 | 13.16 | 12.86 | 13.10 | 830,494 | |
| 06/03/2025 | 12.33 | 13.20 | 11.90 | 13.04 | 876,255 | |
06/02/2025 | 12.60 | 12.63 | 12.08 | 12.32 | 1,265,169 | |
05/30/2025 | 12.49 | 12.82 | 12.13 | 12.66 | 1,190,115 | |
05/29/2025 | 12.81 | 12.96 | 12.38 | 12.68 | 980,825 | |
05/28/2025 | 13.12 | 13.32 | 12.65 | 12.70 | 860,290 | |
05/27/2025 | 12.65 | 13.28 | 12.43 | 13.12 | 1,098,498 | |
| 05/23/2025 | 12.28 | 12.50 | 12.04 | 12.30 | 989,046 | |
05/22/2025 | 12.50 | 12.72 | 12.30 | 12.66 | 1,049,625 | |
05/21/2025 | 13.07 | 13.12 | 12.65 | 12.69 | 1,348,409 | |
05/20/2025 | 13.56 | 13.65 | 13.14 | 13.32 | 1,107,185 | |
05/19/2025 | 13.28 | 13.62 | 13.12 | 13.55 | 1,061,818 | |
05/16/2025 | 13.01 | 13.64 | 12.83 | 13.57 | 956,151 | |
05/15/2025 | 12.86 | 13.09 | 12.46 | 13.01 | 770,927 | |
05/14/2025 | 13.32 | 13.51 | 12.65 | 12.92 | 1,505,393 | |
| 05/13/2025 | 13.63 | 13.77 | 13.02 | 13.51 | 1,254,323 | |
05/12/2025 | 12.95 | 13.93 | 12.95 | 13.67 | 2,315,828 | |
05/09/2025 | 12.89 | 12.89 | 12.13 | 12.25 | 1,542,604 | |
05/08/2025 | 12.87 | 13.53 | 12.75 | 12.89 | 1,733,511 | |
05/07/2025 | 12.81 | 13.27 | 12.63 | 12.73 | 1,486,359 | |
| 05/06/2025 | 13.34 | 13.80 | 12.39 | 12.75 | 2,558,694 | |
05/05/2025 | 14.73 | 14.79 | 11.60 | 13.28 | 7,493,560 | |
05/02/2025 | 16.95 | 17.04 | 16.50 | 16.85 | 1,216,583 | |
05/01/2025 | 16.46 | 16.75 | 15.84 | 16.44 | 1,049,750 | |
04/30/2025 | 17.18 | 17.20 | 16.37 | 16.39 | 863,502 | |
04/29/2025 | 16.66 | 17.54 | 16.41 | 17.35 | 1,064,580 | |
04/28/2025 | 16.91 | 17.31 | 16.45 | 16.69 | 729,287 | |
04/25/2025 | 16.66 | 16.86 | 16.27 | 16.81 | 758,558 | |
04/24/2025 | 16.26 | 16.92 | 15.95 | 16.70 | 494,870 | |
04/23/2025 | 16.28 | 17.26 | 16.18 | 16.26 | 587,794 | |
04/22/2025 | 15.53 | 15.70 | 15.11 | 15.67 | 732,574 | |
04/21/2025 | 15.55 | 15.72 | 14.45 | 15.19 | 1,302,706 | |
04/17/2025 | 15.59 | 15.96 | 15.46 | 15.83 | 429,645 | |
04/16/2025 | 15.97 | 16.35 | 15.51 | 15.75 | 600,273 | |
04/15/2025 | 16.73 | 16.91 | 16.02 | 16.08 | 725,647 | |
04/14/2025 | 17.29 | 17.29 | 16.11 | 16.73 | 844,219 | |
04/11/2025 | 17.46 | 17.46 | 15.95 | 16.99 | 659,620 | |
04/10/2025 | 18.76 | 19.13 | 17.13 | 17.42 | 632,035 | |
04/09/2025 | 17.64 | 19.25 | 16.88 | 19.19 | 1,223,982 | |
04/08/2025 | 20.13 | 20.55 | 17.86 | 18.07 | 830,673 | |
04/07/2025 | 18.77 | 20.41 | 18.53 | 19.58 | 770,282 | |
04/04/2025 | 19.38 | 19.86 | 18.90 | 19.57 | 695,682 | |
04/03/2025 | 21.23 | 21.34 | 20.04 | 20.06 | 545,920 | |
04/02/2025 | 21.19 | 21.88 | 21.19 | 21.78 | 343,383 | |
04/01/2025 | 21.93 | 21.95 | 21.35 | 21.61 | 606,680 | |
03/31/2025 | 21.98 | 22.27 | 21.74 | 21.99 | 617,683 |
About Integra LifeSciences Stock history
Integra LifeSciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Integra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Integra LifeSciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Integra LifeSciences stock prices may prove useful in developing a viable investing in Integra LifeSciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 77 M | 67.8 M | |
| Net Income Applicable To Common Shares | 207.6 M | 218 M |
Integra LifeSciences Quarterly Net Working Capital |
|
Integra LifeSciences Stock Technical Analysis
Integra LifeSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Integra LifeSciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Integra LifeSciences' price direction in advance. Along with the technical and fundamental analysis of Integra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Integra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.32) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (0.61) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.